Alphacentric Lifesci is trading at 13.97 as of the 13th of September 2024; that is 0.07% down since the beginning of the trading day. The fund's open price was 13.98. Alphacentric Lifesci has less than a 17 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. Equity ratings for Alphacentric Lifesci Healthcare are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of August 2024 and ending today, the 13th of September 2024. Click here to learn more.
Under normal market conditions, the fund invests at least 80 percent of its net assets plus borrowings for investment purposes in the securities of companies in the life sciences and healthcare sectors, which the managers define to be the category of companies related to producing or supplying facilities, supplies, technology, pharmaceuticals, equipment, devices or services for the preservation and care of a persons or animals health.. More on Alphacentric Lifesci Healthcare
Alphacentric Lifesci Healthcare [LYFAX] is traded in USA and was established 13th of September 2024. Alphacentric Lifesci is listed under AlphaCentric Funds category by Fama And French industry classification. The fund is listed under Health category and is part of AlphaCentric Funds family. The entity is thematically classified as Healthcare Funds. This fund now has accumulated 99.21 M in assets with no minimum investment requirementsAlphacentric Lifesci is currently producing year-to-date (YTD) return of 7.33%, while the total return for the last 3 years was 1.28%.
Check Alphacentric Lifesci Probability Of Bankruptcy
Instrument Allocation
Top Alphacentric Lifesci Healthcare Mutual Fund Constituents
Other Information on Investing in Alphacentric Mutual Fund
Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.